BioSpace News Archive

Neovasc Inc . (“Neovasc” or the “Company”) ( Nasdaq , TSX : NVCN) announced today that EuroIntervention , the official journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI), has published online a peer-reviewed study announcing the outcomes of patients undergoing Neovasc Reducer™ (“Reducer”) implantation in

Company obtains exclusive rights to develop and commercialize antibody therapeutics targeting insulin-like growth factor-1 receptor (IGF-1R) using Xencor’s Xtend™ half-life extension technology miRagen expects to file an Investigational New Drug (IND) application for VRDN-002, including half-life extension, by the end of 2021

- Proceeds Received from Registered Direct Offering, Warrant Exercises and Upfront Fee from China Out-licensing - - Improved Cash Position Will Support Clinical Development Programs for Galinpepimut-S - NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced the closi

Tarsier Pharma (doing business as Tarsius Pharma Ltd.), a late clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients with blinding ocular diseases, today announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA),

TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH)

As we head into the winter months, Canadians are doing everything they can protect themselves from the risk of getting sick. It turns out that if you DO find yourself in hospital, you may face a different set of risks – the risk of receiving the wrong medication based on your genetics. Now, a new test can help.

EVERSANA ™, the pioneer of next-generation commercial services to the life sciences industry, and Experic , a contract manufacturing organization (CMO) and pharmaceutical supply service company, today announced a collaboration to optimize clinical development, manufacturing, launch planning and commercialization efforts

The COVID-19 pandemic is a global public health crisis that has placed an increased focus on the importance of vaccination.

Asembia’s 2021 Specialty Pharmacy Summit will take place October 26 through October 29, 2021 at the Wynn Las Vegas. The date change for 2021 is due to challenges from COVID -19 which have disrupte

Allterum Therapeutics, Inc. completed its $1.8 million Series Seed offering to members of the FanninDirect SM investor group. Allterum is developing a novel immunotherapy for treatment of IL7R-expressing cancers, including difficult to treat cases of pediatric acute lymphoblastic leukemia (ALL), a program which has received both Orph